Compounds > l 740093
Page last updated: 2024-09-04

l 740093 and ym 022

l 740093 has been researched along with ym 022 in 5 studies

Compound Research Comparison

Studies
(l 740093)		Trials
(l 740093)		Recent Studies (post-2010)
(l 740093)		Studies
(ym 022)		Trials
(ym 022)		Recent Studies (post-2010) (ym 022)
16006518

Protein Interaction Comparison

ProteinTaxonomyl 740093 (IC50)ym 022 (IC50)
Cholecystokinin receptor type ARattus norvegicus (Norway rat)0.146
Gastrin/cholecystokinin type B receptorRattus norvegicus (Norway rat)0.0001

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Håkanson, R; Lindström, E; Monstein, HJ; Nilsson, I; Svensson, S1
Ding, XQ; Håkanson, R1
Beinborn, M; Kopin, AS; Quinn, SM1
Dunlop, J1
Beinborn, M; Bläker, M; Gordon, MC; Hsu, JE; Kopin, AS; Ren, Y1

Reviews

1 review(s) available for l 740093 and ym 022

ArticleYear
CCK receptor antagonists.
    General pharmacology, 1998, Volume: 31, Issue:4

    Topics: Animals; Benzodiazepines; Benzodiazepinones; Cells, Cultured; Humans; Phenylurea Compounds; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin

1998

Other Studies

4 other study(ies) available for l 740093 and ym 022

ArticleYear
Pharmacological analysis of CCK(2) receptor ligands using COS-7 and SK-N-MC cells, expressing the human CCK(2) receptor.
    Regulatory peptides, 2002, Jan-15, Volume: 103, Issue:1

    Topics: Animals; Binding Sites; Binding, Competitive; Cell Line; Cell Membrane; COS Cells; Gene Expression; Guanosine Triphosphate; Humans; Kinetics; Ligands; Models, Theoretical; Neuroblastoma; Radioligand Assay; Receptor, Cholecystokinin B; Receptors, Cell Surface; Receptors, Cholecystokinin; Structure-Activity Relationship; Transfection; Tumor Cells, Cultured

2002
Evaluation of the specificity and potency of a series of cholecystokinin-B/gastrin receptor antagonists in vivo.
    Pharmacology & toxicology, 1996, Volume: 79, Issue:3

    Topics: Analysis of Variance; Animals; Anti-Ulcer Agents; Benzodiazepines; Benzodiazepinones; Dose-Response Relationship, Drug; Female; Gastric Emptying; Gastric Mucosa; Histidine Decarboxylase; Hormone Antagonists; Infusions, Intravenous; Lethal Dose 50; Male; Mice; Phenylurea Compounds; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Structure-Activity Relationship

1996
Minor modifications of a cholecystokinin-B/gastrin receptor non-peptide antagonist confer a broad spectrum of functional properties.
    The Journal of biological chemistry, 1998, Jun-05, Volume: 273, Issue:23

    Topics: Animals; Benzodiazepines; Benzodiazepinones; Binding, Competitive; COS Cells; Hormone Antagonists; Inositol Phosphates; Molecular Structure; Mutation; Peptides; Phenylurea Compounds; Receptors, Cholecystokinin; Signal Transduction; Transfection

1998
Mutations within the cholecystokinin-B/gastrin receptor ligand 'pocket' interconvert the functions of nonpeptide agonists and antagonists.
    Molecular pharmacology, 1998, Volume: 54, Issue:5

    Topics: Animals; Benzodiazepines; Benzodiazepinones; Binding Sites; Cell Membrane; COS Cells; DNA, Complementary; Hormone Antagonists; Humans; Inositol Phosphates; Iodine Radioisotopes; Ligands; Mutagenesis, Site-Directed; Mutation; Phenylurea Compounds; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Sincalide

1998